JPRN-UMIN000008999招募中2 期
Dasatinib discontinuation for Chronic Myelogenous Leukemia-Chronic Phase with One Year Complete Molecular Remission. - IMIDAS(Inter-Michinoku dasatinib study) 3rd Trial
Epidemiological and Clinical Research Information Network(ECRIN)0 个研究点目标入组 50 人开始时间: 2012年9月28日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 15years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Concurrent malignancy other than CML 2.Women who are pregnant or breastfeeding 3. A serious uncontrolled medical disorder that would impair the ability of the subjects to receive protocol therapy 4.Subjects with T315I, F317L and V299L BCR-ABL point mutations 5.Subjects with clonal evolution
研究者
相似试验
已完成
2 期
Dasatinib discontinuation for Chronic Myelogenous Leukemia-Chronic Phase with One Year Complete Molecular Remission.chronic myeloid leukemiaJPRN-UMIN000005130Epidemiological and Clinical Research Information Network (ECRIN)50
招募中
2 期
Imatinib discontinuation for Chronic Myelogenou Leukemia-Chronic Phase with 2 years complete molecular remission.Chronic Myelogenou Leukemia-Chronic Phase who have maintained complete molecular remission for at least 2 years.JPRN-UMIN000012472Epidemiological and Clinical Research Information Network (ECRIN)100
已完成
不适用
DASATINIB IN SUBJECTS WITH CHRONIC MYELOID LEUKEMIA OR ACUTE LYMPHOBLASTIC LEUKEMIA WITH POSITIVE PHILADELPHIA CHROMOSOME EXPERIMENTING CLINICAL BENEFITS IN CURRENT START PROTOCOLS: LONG-TERM SECURITY AND EFFECTIVENESS ANALYSIS-C921 Chronic myeloid leukaemia [CML], BCR/ABL-positiveChronic myeloid leukaemia [CML], BCR/ABL-positiveC921PER-082-07BRISTOL MYERS SQUIBB COMPANY,8
Unknown
2 期
Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop TrialChronic Myeloid LeukemiaNCT01627132Shimousa Hematology Study Group50
招募中
不适用
Stop imatinib or dasatinib study in CP-CML patients mainitaining complete molecular response for two yearschronic phase chronic myeloid leukemiaJPRN-UMIN000007944Tokyo Women's Medical University40